Alvotech (ALVOW) Competitors $1.65 -0.13 (-7.30%) As of 07/11/2025 10:30 AM Eastern Add Compare Share Share Competitors Stock AnalysisChartCompetitorsFinancialsSEC FilingsShort InterestTrendsBuy This Stock ALVOW vs. ATNFW, LBPSW, AEHAW, AIMDW, AMPE, ARAV, ACABW, BFRIW, BTMDW, and BCTXWShould you be buying Alvotech stock or one of its competitors? The main competitors of Alvotech include 180 Life Sciences (ATNFW), 4D pharma (LBPSW), Aesther Healthcare Acquisition (AEHAW), Ainos (AIMDW), Ampio Pharmaceuticals (AMPE), ARAVIVE (ARAV), Atlantic Coastal Acquisition Corp. II (ACABW), Biofrontera (BFRIW), biote (BTMDW), and BriaCell Therapeutics (BCTXW). These companies are all part of the "pharmaceutical products" industry. Alvotech vs. Its Competitors 180 Life Sciences 4D pharma Aesther Healthcare Acquisition Ainos Ampio Pharmaceuticals ARAVIVE Atlantic Coastal Acquisition Corp. II Biofrontera biote BriaCell Therapeutics 180 Life Sciences (NASDAQ:ATNFW) and Alvotech (NASDAQ:ALVOW) are both medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their analyst recommendations, risk, dividends, media sentiment, profitability, valuation, earnings and institutional ownership. Is ATNFW or ALVOW more profitable? Company Net Margins Return on Equity Return on Assets 180 Life SciencesN/A N/A N/A Alvotech N/A N/A N/A Does the media favor ATNFW or ALVOW? In the previous week, 180 Life Sciences and 180 Life Sciences both had 1 articles in the media. 180 Life Sciences' average media sentiment score of 1.87 equaled Alvotech'saverage media sentiment score. Company Overall Sentiment 180 Life Sciences Very Positive Alvotech Very Positive Which has better earnings and valuation, ATNFW or ALVOW? CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio180 Life SciencesN/AN/AN/AN/AN/AAlvotech$585.60MN/AN/AN/AN/A SummaryAlvotech beats 180 Life Sciences on 1 of the 1 factors compared between the two stocks. Get Alvotech News Delivered to You Automatically Sign up to receive the latest news and ratings for ALVOW and its competitors with MarketBeat's FREE daily newsletter. Email Address Media Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart ALVOW vs. The Competition Export to ExcelMetricAlvotechDrug Manufacturers IndustryMedical SectorNASDAQ ExchangeMarket CapN/A$2.18B$5.60B$9.11BDividend YieldN/A2.92%5.24%4.02%P/E RatioN/A4.1527.9620.25Price / SalesN/A562.62430.5799.61Price / CashN/A10.3537.4658.16Price / BookN/A11.478.045.49Net IncomeN/A$21.15B$3.18B$250.27M7 Day Performance-4.62%0.32%3.63%4.75%1 Month Performance-14.95%5.94%4.04%7.64%1 Year Performance-42.11%2.25%29.56%16.34% Alvotech Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)ALVOWAlvotechN/A$1.65-7.3%N/A-42.1%$0.00$585.60M0.004Positive NewsGap DownATNFW180 Life SciencesN/A$0.01-4.7%N/A-2.4%$0.00N/A0.007Positive NewsGap DownLBPSW4D pharmaN/AN/AN/AN/A$0.00$522K0.00N/AAEHAWAesther Healthcare AcquisitionN/A$0.01-9.0%N/A-83.4%$0.00N/A0.002Gap DownAIMDWAinosN/A$0.12-7.7%N/A+70.4%$0.00$106.21K0.0040Gap DownAMPEAmpio PharmaceuticalsN/A$0.00-96.3%N/A-99.9%$0.00N/A0.0020Gap DownARAVARAVIVEN/A$0.04flatN/AN/A$0.00$9.14M0.0020High Trading VolumeACABWAtlantic Coastal Acquisition Corp. IIN/A$0.02flatN/AN/A$0.00N/A0.0015BFRIWBiofronteraN/A$0.11+16.9%N/A+213.1%$0.00$38.00M0.0070Positive NewsGap UpBTMDWbioteN/A$0.01-19.7%N/A-97.5%$0.00$199.38M0.00N/AGap DownBCTXWBriaCell TherapeuticsN/A$0.08+6.0%N/A-62.1%$0.00N/A0.008Gap Down Related Companies and Tools Related Companies 180 Life Sciences Competitors 4D pharma Competitors Aesther Healthcare Acquisition Competitors Ainos Competitors Ampio Pharmaceuticals Competitors ARAVIVE Competitors Atlantic Coastal Acquisition Corp. II Competitors Biofrontera Competitors biote Competitors BriaCell Therapeutics Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:ALVOW) was last updated on 7/12/2025 by MarketBeat.com Staff From Our PartnersTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredBuffett’s $325 Billion Cash Problem — Solved by Gold?A bombshell announcement is just weeks away — and it could send shockwaves through the gold market. Most inves...Golden Portfolio | SponsoredThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | SponsoredTrump’s New Order Could Boost Social Security Benefits by 400%If you collect—or plan to collect—Social Security, you need to see this. A new initiative tied to President...InvestorPlace | SponsoredGoogle did what!?!?A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Alvotech Please log in to your account or sign up in order to add this asset to your watchlist. Share Alvotech With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
